481
Views
2
CrossRef citations to date
0
Altmetric
Interview

Minimalization of immunosuppression in liver transplantation: steps from ’how’ to ’now’

Pages 605-607 | Published online: 10 Jan 2014
 

Abstract

From the very start of his surgical career, Jan Lerut was involved in organ transplantation. This interest resulted in transplantation fellowships at the University Paris-Sud – Centre Hépatobiliaire under the lead of Professor Bismuth and at the Pittsburgh Medical Center under the lead of Professor Starzl. He was director of the abdominal transplant program at the Inselspital University of Bern from 1987 to 1991. Currently, he is Professor of Surgery, Director of the Starzl Abdominal Transplant Unit of the University Hospitals Saint Luc of the Université Catholique de Louvain and director of the Université Catholique de Louvain Transplant Center in Brussels. He is also director of the department of Abdominal and Transplantation Surgery at the same university. He has served as president of the Belgian Society of Transplantation, chairman of the Eurotransplant Liver Allocation Committee and president of the European Society for Organ Transplantation. Under his presidency over the Eurotransplant Liver Allocation Committee, the Model for End stage Liver Disease system was introduced. His presidency at the European Society for Organ Transplantation was devoted to the broadening of the European transplant community and to the development of a master educational program in the field of transplantation. He has published over 250 peer-reviewed articles, authored 24 book chapters and 24 scientific films. His research interests focus on the development of technical refinements in liver transplantation and on the use of minimal immunosuppression and tolerance induction in liver transplantation.

Financial & competing interests disclosure

Lerut has received an unrestricted grant from Fresenius Biotech and Astelellas for an investigator-driven study. The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.